ArticleCancer medicine2023

MAPK4 predicts poor prognosis and facilitates the proliferation and migration of glioma through the AKT/mTOR pathway.

Jing Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.